×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded ...
Morningstar
70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-...
3 days ago
Tiziana Life Sciences wins FDA approval to add patients to Multiple Sclerosis Expanded Access Program
Proactive financial news
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has been approved by the US Food and Drug Administration to expand patient...
2 days ago
Tiziana Life Sciences (TLSA) Announces Additional Clinical Improvements Among Multiple Sclerosis Patients
StreetInsider.com
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation...
3 days ago
Tiziana Life Sciences' MS Treatment Shows Potential - TipRanks.com
Tipranks
Tiziana Life Sciences (US) (TLSA) has released an update. Tiziana Life Sciences has announced promising study results for their intranasal...
6 days ago
Tiziana Life Sciences reports additional positive results from Multiple Sclerosis program
Proactive Investors
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled additional positive results from its Expanded Access Program for patients with...
2 days ago
Tiziana stock spikes as FDA widens expanded access program (NASDAQ:TLSA)
Seeking Alpha
Tiziana Life Sciences (TLSA) stock gains as the FDA expands its Expanded Access Program for foralumab, a potential treatment for multiple...
2 days ago
TLSA: First Phase II SPMS Patient Dosed
Yahoo Finance
By John Vandermosten, CFA NASDAQ:TLSA Tiziana Life Sciences PLC (NASDAQ:TLSA) has achieved a significant milestone dosing its first patient...
3 months ago
4 new SPMS patients dosed with nasal foralumab outside of trials
Multiple Sclerosis News Today
Tiziana Life Sciences has dosed four new participants in an expanded access program investigating its foralumab nasal spray in people with...
4 months ago
Tiziana Life Sciences announces additional clinical improvements in EAP - TipRanks.com
Tipranks
Tiziana Life Sciences announced additional positive clinical results from its intermediate sized Expanded Access Program, EAP,...
3 days ago
Tiziana Life Sciences' foralumab study highlighted in Neurology Today
Proactive financial news
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its study on foralumab, the company's lead candidate, was published in Neurology Today,...
5 days ago